Filters
Other countries
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 195 | 221 |
|
ALDH4A1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 669 | 688 |
|
Centogene AG - the Rare Disease Company Germany | 406 | 414 |
|
Centogene AG - the Rare Disease Company Germany | 829 | 848 |
|
Invitae Comprehensive Neurometabolic Disorders Panel Invitae United States | 351 | 249 |
|
ALDH4A1 - Hyperprolinemia type II Translational Metabolic Laboratory Radboud University Medical Centre Netherlands | 1 | 1 |
|
Invitae Treatable Neurometabolic Disorders Panel Invitae United States | 257 | 191 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 328 | 300 |
|
Invitae Metabolic Newborn Screening Confirmation Panel Invitae United States | 201 | 158 |
|
Baylor Genetics United States | 1 | 1 |
|
ALDH4A1 Sequence & Deletion/Duplication Analysis Baylor Genetics United States | 1 | 1 |
|
ALDH4A1 Prenatal Sequence Analysis Baylor Genetics United States | 1 | 1 |
|
ALDH4A1 Familial Mutation/Variant Analysis Baylor Genetics United States | 1 | 1 |
|
ALDH4A1 Deletion/Duplication Analysis Baylor Genetics United States | 1 | 1 |
|
Baylor Genetics United States | 842 | 637 |
|
Fulgent Genetics United States | 509 | 275 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.